Propranolol and cancer

Zehra Pınar Cengiz, Oytun Erbaş

DOI: 10.5606/fng.transplantasyon.2018.008

Issue: 2018, Volume 3 - Issue 1-2
0 2344

Relationship of sleep, melatonin, and cancer

Ali Çimen, Yasemin Akbaş, Oytun Erbaş

DOI: 10.5606/fng.transplantasyon.2018.009

Issue: 2018, Volume 3 - Issue 1-2
0 3974

Natural health products that inhibit tumoral angiogenesis

Emin Taşkıran, Harun Akar, Oytun Erbaş

DOI: 10.5606/fng.transplantasyon.2017.001

Issue: 2017, Volume 2 - Issue 1
0 1734

Solid organ transplantation and vascularized composite allotransplantation: Past and present

Burak Sercan Erçin, Kubilay Doğan Kılıç, Yiğit Özer Tiftikçioğlu, Ahmet Biçer, Yiğit Uyanıkgil, Alessandro Thione, Tahir Gürler

DOI: 10.5606/fng.transplantasyon.2017.002

Issue: 2017, Volume 2 - Issue 1
0 1797

Cancer immunotherapy

Ahmet Anıl Özlük, Merve Güner Oytun, Damla Günenç

DOI: 10.5606/fng.transplantasyon.2017.004

Issue: 2017, Volume 2 - Issue 1
0 2493

The role of angiogenesis in physiological and pathological conditions

Rasim Hamutoğlu, Ozan Önder

DOI: 10.5606/fng.transplantasyon.2017.010

Issue: 2017, Volume 2 - Issue 2
0 3102

Corneal transplantation and immunosuppressants

Pakize Nur Akkaya, Oytun Erbaş

DOI: 10.5606/dsufnjt.2019.001

Issue: 2019, Volume 4 - Issue 1-2
8449 2453

Non-small cell lung cancer and its treatment

Havvanur Akbulut, Semanur İncedayı, Özüm Atasoy

DOI: 10.5606/dsufnjt.2019.004

Issue: 2019, Volume 4 - Issue 1-2
2864 2017

Intestinal transplantation

Mine Ün, Oytun Erbaş

DOI: 10.5606/dsufnjt.2019.007

Issue: 2019, Volume 4 - Issue 1-2
2515 2129

Urinary tumor markers for diagnosis of prostate cancer

Mine Ün, Mustafa Sel

DOI: 10.5606/dsufnjt.2019.010

Issue: 2019, Volume 4 - Issue 1-2
2357 2089

Repigmentation observed in hair due to cancer immunotherapy

Esra Nur Arslan, Oytun Erbaş

DOI: 10.5606/fng.transplantasyon.2018.004

Issue: 2018, Volume 3 - Issue 1-2
4064 1743

PD-1, PD-L1 mechanism and cancer treatment

Aslı Babayakalı, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.019

Issue: 2021, Volume 6 - Issue 1-2
1284 1484

Tumor markers and clinical use

Burak Akverdi, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.023

Issue: 2021, Volume 6 - Issue 1-2
2476 4074

Alkaliptosis: A new strategy for cancer therapy

Beyza Emine Kılınç, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.024

Issue: 2021, Volume 6 - Issue 1-2
1798 1811

Bone marrow transplantation use on treatment solid tumors

İlayda Üzümcü, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.026

Issue: 2021, Volume 6 - Issue 1-2
1360 1513

Cancer cells and alpha-ketoglutarate

Yalda Sadeghian, İlayda Üzümcü, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.029

Issue: 2021, Volume 6 - Issue 1-2
1795 2213

The role of oxytocin and prolactin in breast carcinogenesis and breast cancer prognosis: A mini-review

Umut Yücel, Oytun Erbaş

DOI: 10.5606/dsufnjt.2022.3

Issue: 2022, Volume 7 - Issue 1-2
1829 1178

Post-transplant infectious complications and therapeutic approaches

Zümer Duman, Oytun Erbaş

DOI: 10.5606/dsufnjt.2022.5

Issue: 2022, Volume 7 - Issue 1-2
2401 1201

NOX-4: A key player in protecting against cancer from free radicals

Şehri Çolak, Oytun Erbaş

DOI: 10.5606/dsufnjt.2023.16

Issue: 2023, Volume 8 - Issue 1&2
1790 1067

Interleukin-35: Immunosuppressive mechanisms in cancer and autoimmune diseases

Gökçen Kılınç, Oytun Erbaş

DOI: 10.5606/dsufnjt.2024.18

Issue: 2024, Volume 9 - Issue 1&2
533 567